Ascendis Pharma A (ASND) Share-based Compensation (2014 - 2026)
Ascendis Pharma A's Share-based Compensation came in at $34.42 million for the quarter ended Jun 30, 2026, up 1.3% from $33.98 million a year earlier but down 3.2% from the prior quarter.
Ascendis Pharma A (ASND) Share-based Compensation (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ascendis Pharma A reported Share-based Compensation of $140.64 million, up 19.8% year-over-year; for the year ended Dec 31, 2025, it was $131.25 million, up 27.0% from the prior year.
- Share-based Compensation has increased in each of the last three years, with a five-year compound annual growth rate of 15.7% (years ended Dec 2020 to Dec 2025).
- Going back by year, Share-based Compensation was $103.38 million in the year ended Dec 31, 2024 (+43.4%), $72.11 million in the year ended Dec 31, 2023 (+6.6%), $67.64 million in the year ended Dec 31, 2022 (-11.5%) and $76.45 million in the year ended Dec 31, 2021 (+20.6%).
- The five-year range for quarterly Share-based Compensation is $13.65 million (the quarter ended Sep 30, 2022) to $35.82 million (the quarter ended Sep 30, 2025).
- Year-over-year, Share-based Compensation has increased for 13 consecutive quarters, with growth averaging 33.0% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in the quarter ended Dec 31, 2024 (growth of 63.7%), and the weakest in the quarter ended Mar 31, 2023 (a decline of 34.4%).
- Business Quant data shows ASND's Share-based Compensation at $35.54 million (quarter ended Mar 31, 2026), $34.87 million (quarter ended Dec 31, 2025) and $35.82 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Ascendis Pharma A | 14.26 Bn | 10.50 Bn | 362.22 Mn | 34.42 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.42 Mn |
| Mar 31, 2026 | 35.54 Mn |
| Dec 31, 2025 | 34.87 Mn |
| Sep 30, 2025 | 35.82 Mn |
| Jun 30, 2025 | 33.98 Mn |
| Mar 31, 2025 | 26.88 Mn |
| Dec 31, 2024 | 28.02 Mn |
| Sep 30, 2024 | 28.51 Mn |
| Jun 30, 2024 | 28.05 Mn |
| Mar 31, 2024 | 18.77 Mn |
| Dec 31, 2023 | 17.12 Mn |
| Sep 30, 2023 | 18.71 Mn |
| Jun 30, 2023 | 21.65 Mn |
| Mar 31, 2023 | 14.69 Mn |
| Dec 31, 2022 | 14.15 Mn |
| Sep 30, 2022 | 13.65 Mn |
| Jun 30, 2022 | 17.93 Mn |
| Mar 31, 2022 | 22.41 Mn |
| Dec 31, 2021 | 16.18 Mn |
| Sep 30, 2021 | 15.67 Mn |
Ascendis Pharma A Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();